Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Renin-angiotensin system at the heart of COVID-19 pandemic.

Identifieur interne : 000769 ( Main/Exploration ); précédent : 000768; suivant : 000770

Renin-angiotensin system at the heart of COVID-19 pandemic.

Auteurs : Marco Alifano [France] ; Pietro Alifano [Italie] ; Patricia Forgez [France] ; Antonio Iannelli [France]

Source :

RBID : pubmed:32305506

Descripteurs français

English descriptors

Abstract

Significant aspects of COVID-19 pandemic remain obscure. Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system, whose expression dominates on lung alveolar epithelial cells, is the human cell receptor of SARS-CoV-2, the causative agent of COVID-19. We strongly encourage the concept that thorough considerations of receptor-ligand interactions should be kept at the heart of scientific debate on infection. In this idea, the whole renin-angiotensin system has to be evaluated. We hypothesize that factors related to ethnicity, environment, behaviors, associated illness, and medications involving this complex system are probably responsible for situations regarded as anomalous from both an epidemiological and a clinical point of view, but, taken together, such factors may explain most of the aspects of current outbreak. We decided to use the analogy of a play and speculate about the possible impact in this tragedy of 1) air pollution via the interference of nitrogen dioxide on ACE2 expression; 2) the dual role of nicotine; 3) the hypothetical involvement of ACE2 polymorphisms, the relationships of which with ethnic factors and susceptibility to cardiovascular disease seems intriguing; 4) the impact on the severity of infection of hypertension and related medications acting on the renin/angiotensin system, and, finally, 5) the possible helpful role of chloroquine, thanks to its capacity of modifying ACE2 affinity to the viral spike protein by altering glycosylation. This hypothesis paper is an urgent call for the development of research programs that aim at questioning whether the putative protagonists of this tragedy are real-life actors in COVID-19.

DOI: 10.1016/j.biochi.2020.04.008
PubMed: 32305506
PubMed Central: PMC7161528


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Renin-angiotensin system at the heart of COVID-19 pandemic.</title>
<author>
<name sortKey="Alifano, Marco" sort="Alifano, Marco" uniqKey="Alifano M" first="Marco" last="Alifano">Marco Alifano</name>
<affiliation wicri:level="1">
<nlm:affiliation>Thoracic Surgery Department, Cochin Hospital, APHP Centre, University of Paris, France; INSERM U1138 Team «Cancer, Immune Control, and Escape», Cordeliers Research Center, University of Paris, France. Electronic address: marco.alifano@aphp.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Thoracic Surgery Department, Cochin Hospital, APHP Centre, University of Paris, France; INSERM U1138 Team «Cancer, Immune Control, and Escape», Cordeliers Research Center, University of Paris</wicri:regionArea>
<wicri:noRegion>University of Paris</wicri:noRegion>
<wicri:noRegion>University of Paris</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Alifano, Pietro" sort="Alifano, Pietro" uniqKey="Alifano P" first="Pietro" last="Alifano">Pietro Alifano</name>
<affiliation wicri:level="1">
<nlm:affiliation>Chair of Microbiology, Department of Biological and Environmental Sciences and Technologies, Salento University, Lecce, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Chair of Microbiology, Department of Biological and Environmental Sciences and Technologies, Salento University, Lecce</wicri:regionArea>
<wicri:noRegion>Lecce</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Forgez, Patricia" sort="Forgez, Patricia" uniqKey="Forgez P" first="Patricia" last="Forgez">Patricia Forgez</name>
<affiliation wicri:level="3">
<nlm:affiliation>Inserm UMR-S 1124 T3S, Eq 5 CELLULAR HOMEOSTASIS, CANCER and THERAPY, University of Paris, Campus Saint Germain, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm UMR-S 1124 T3S, Eq 5 CELLULAR HOMEOSTASIS, CANCER and THERAPY, University of Paris, Campus Saint Germain, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Iannelli, Antonio" sort="Iannelli, Antonio" uniqKey="Iannelli A" first="Antonio" last="Iannelli">Antonio Iannelli</name>
<affiliation wicri:level="1">
<nlm:affiliation>Digestive Disease Department, Archet 2 Hospital, Nice University Hospital, University of Nice Côte d'Azur, Nice, France; Inserm, U1065, Team 8 "Hepatic Complications of Obesity", University Nice Côte d'Azur, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Digestive Disease Department, Archet 2 Hospital, Nice University Hospital, University of Nice Côte d'Azur, Nice, France; Inserm, U1065, Team 8 "Hepatic Complications of Obesity", University Nice Côte d'Azur</wicri:regionArea>
<wicri:noRegion>University Nice Côte d'Azur</wicri:noRegion>
<wicri:noRegion>University Nice Côte d'Azur</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32305506</idno>
<idno type="pmid">32305506</idno>
<idno type="doi">10.1016/j.biochi.2020.04.008</idno>
<idno type="pmc">PMC7161528</idno>
<idno type="wicri:Area/Main/Corpus">001676</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001676</idno>
<idno type="wicri:Area/Main/Curation">001676</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001676</idno>
<idno type="wicri:Area/Main/Exploration">001676</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Renin-angiotensin system at the heart of COVID-19 pandemic.</title>
<author>
<name sortKey="Alifano, Marco" sort="Alifano, Marco" uniqKey="Alifano M" first="Marco" last="Alifano">Marco Alifano</name>
<affiliation wicri:level="1">
<nlm:affiliation>Thoracic Surgery Department, Cochin Hospital, APHP Centre, University of Paris, France; INSERM U1138 Team «Cancer, Immune Control, and Escape», Cordeliers Research Center, University of Paris, France. Electronic address: marco.alifano@aphp.fr.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Thoracic Surgery Department, Cochin Hospital, APHP Centre, University of Paris, France; INSERM U1138 Team «Cancer, Immune Control, and Escape», Cordeliers Research Center, University of Paris</wicri:regionArea>
<wicri:noRegion>University of Paris</wicri:noRegion>
<wicri:noRegion>University of Paris</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Alifano, Pietro" sort="Alifano, Pietro" uniqKey="Alifano P" first="Pietro" last="Alifano">Pietro Alifano</name>
<affiliation wicri:level="1">
<nlm:affiliation>Chair of Microbiology, Department of Biological and Environmental Sciences and Technologies, Salento University, Lecce, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Chair of Microbiology, Department of Biological and Environmental Sciences and Technologies, Salento University, Lecce</wicri:regionArea>
<wicri:noRegion>Lecce</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Forgez, Patricia" sort="Forgez, Patricia" uniqKey="Forgez P" first="Patricia" last="Forgez">Patricia Forgez</name>
<affiliation wicri:level="3">
<nlm:affiliation>Inserm UMR-S 1124 T3S, Eq 5 CELLULAR HOMEOSTASIS, CANCER and THERAPY, University of Paris, Campus Saint Germain, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Inserm UMR-S 1124 T3S, Eq 5 CELLULAR HOMEOSTASIS, CANCER and THERAPY, University of Paris, Campus Saint Germain, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Iannelli, Antonio" sort="Iannelli, Antonio" uniqKey="Iannelli A" first="Antonio" last="Iannelli">Antonio Iannelli</name>
<affiliation wicri:level="1">
<nlm:affiliation>Digestive Disease Department, Archet 2 Hospital, Nice University Hospital, University of Nice Côte d'Azur, Nice, France; Inserm, U1065, Team 8 "Hepatic Complications of Obesity", University Nice Côte d'Azur, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Digestive Disease Department, Archet 2 Hospital, Nice University Hospital, University of Nice Côte d'Azur, Nice, France; Inserm, U1065, Team 8 "Hepatic Complications of Obesity", University Nice Côte d'Azur</wicri:regionArea>
<wicri:noRegion>University Nice Côte d'Azur</wicri:noRegion>
<wicri:noRegion>University Nice Côte d'Azur</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Biochimie</title>
<idno type="eISSN">1638-6183</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Cardiovascular Diseases (complications)</term>
<term>Coronavirus Infections (complications)</term>
<term>Coronavirus Infections (metabolism)</term>
<term>Coronavirus Infections (physiopathology)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hypertension (complications)</term>
<term>Male (MeSH)</term>
<term>Middle Aged (MeSH)</term>
<term>Pandemics (MeSH)</term>
<term>Peptidyl-Dipeptidase A (genetics)</term>
<term>Peptidyl-Dipeptidase A (metabolism)</term>
<term>Pneumonia, Viral (complications)</term>
<term>Pneumonia, Viral (metabolism)</term>
<term>Pneumonia, Viral (physiopathology)</term>
<term>Renin-Angiotensin System (physiology)</term>
<term>Risk Factors (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adulte d'âge moyen (MeSH)</term>
<term>Betacoronavirus (MeSH)</term>
<term>Facteurs de risque (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hypertension artérielle (complications)</term>
<term>Infections à coronavirus (complications)</term>
<term>Infections à coronavirus (métabolisme)</term>
<term>Infections à coronavirus (physiopathologie)</term>
<term>Maladies cardiovasculaires (complications)</term>
<term>Mâle (MeSH)</term>
<term>Pandémies (MeSH)</term>
<term>Peptidyl-Dipeptidase A (génétique)</term>
<term>Peptidyl-Dipeptidase A (métabolisme)</term>
<term>Pneumopathie virale (complications)</term>
<term>Pneumopathie virale (métabolisme)</term>
<term>Pneumopathie virale (physiopathologie)</term>
<term>Sujet âgé (MeSH)</term>
<term>Système rénine-angiotensine (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Peptidyl-Dipeptidase A</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Cardiovascular Diseases</term>
<term>Coronavirus Infections</term>
<term>Hypertension</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Hypertension artérielle</term>
<term>Infections à coronavirus</term>
<term>Maladies cardiovasculaires</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Peptidyl-Dipeptidase A</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Système rénine-angiotensine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Renin-Angiotensin System</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Betacoronavirus</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Pandemics</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte d'âge moyen</term>
<term>Betacoronavirus</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Pandémies</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Significant aspects of COVID-19 pandemic remain obscure. Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system, whose expression dominates on lung alveolar epithelial cells, is the human cell receptor of SARS-CoV-2, the causative agent of COVID-19. We strongly encourage the concept that thorough considerations of receptor-ligand interactions should be kept at the heart of scientific debate on infection. In this idea, the whole renin-angiotensin system has to be evaluated. We hypothesize that factors related to ethnicity, environment, behaviors, associated illness, and medications involving this complex system are probably responsible for situations regarded as anomalous from both an epidemiological and a clinical point of view, but, taken together, such factors may explain most of the aspects of current outbreak. We decided to use the analogy of a play and speculate about the possible impact in this tragedy of 1) air pollution via the interference of nitrogen dioxide on ACE2 expression; 2) the dual role of nicotine; 3) the hypothetical involvement of ACE2 polymorphisms, the relationships of which with ethnic factors and susceptibility to cardiovascular disease seems intriguing; 4) the impact on the severity of infection of hypertension and related medications acting on the renin/angiotensin system, and, finally, 5) the possible helpful role of chloroquine, thanks to its capacity of modifying ACE2 affinity to the viral spike protein by altering glycosylation. This hypothesis paper is an urgent call for the development of research programs that aim at questioning whether the putative protagonists of this tragedy are real-life actors in COVID-19.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32305506</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>06</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>06</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1638-6183</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>174</Volume>
<PubDate>
<Year>2020</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Biochimie</Title>
<ISOAbbreviation>Biochimie</ISOAbbreviation>
</Journal>
<ArticleTitle>Renin-angiotensin system at the heart of COVID-19 pandemic.</ArticleTitle>
<Pagination>
<MedlinePgn>30-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0300-9084(20)30078-X</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biochi.2020.04.008</ELocationID>
<Abstract>
<AbstractText>Significant aspects of COVID-19 pandemic remain obscure. Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system, whose expression dominates on lung alveolar epithelial cells, is the human cell receptor of SARS-CoV-2, the causative agent of COVID-19. We strongly encourage the concept that thorough considerations of receptor-ligand interactions should be kept at the heart of scientific debate on infection. In this idea, the whole renin-angiotensin system has to be evaluated. We hypothesize that factors related to ethnicity, environment, behaviors, associated illness, and medications involving this complex system are probably responsible for situations regarded as anomalous from both an epidemiological and a clinical point of view, but, taken together, such factors may explain most of the aspects of current outbreak. We decided to use the analogy of a play and speculate about the possible impact in this tragedy of 1) air pollution via the interference of nitrogen dioxide on ACE2 expression; 2) the dual role of nicotine; 3) the hypothetical involvement of ACE2 polymorphisms, the relationships of which with ethnic factors and susceptibility to cardiovascular disease seems intriguing; 4) the impact on the severity of infection of hypertension and related medications acting on the renin/angiotensin system, and, finally, 5) the possible helpful role of chloroquine, thanks to its capacity of modifying ACE2 affinity to the viral spike protein by altering glycosylation. This hypothesis paper is an urgent call for the development of research programs that aim at questioning whether the putative protagonists of this tragedy are real-life actors in COVID-19.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Alifano</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Thoracic Surgery Department, Cochin Hospital, APHP Centre, University of Paris, France; INSERM U1138 Team «Cancer, Immune Control, and Escape», Cordeliers Research Center, University of Paris, France. Electronic address: marco.alifano@aphp.fr.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Alifano</LastName>
<ForeName>Pietro</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Chair of Microbiology, Department of Biological and Environmental Sciences and Technologies, Salento University, Lecce, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Forgez</LastName>
<ForeName>Patricia</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Inserm UMR-S 1124 T3S, Eq 5 CELLULAR HOMEOSTASIS, CANCER and THERAPY, University of Paris, Campus Saint Germain, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Iannelli</LastName>
<ForeName>Antonio</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Digestive Disease Department, Archet 2 Hospital, Nice University Hospital, University of Nice Côte d'Azur, Nice, France; Inserm, U1065, Team 8 "Hepatic Complications of Obesity", University Nice Côte d'Azur, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>04</Month>
<Day>16</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>France</Country>
<MedlineTA>Biochimie</MedlineTA>
<NlmUniqueID>1264604</NlmUniqueID>
<ISSNLinking>0300-9084</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>EC 3.4.15.1</RegistryNumber>
<NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>EC 3.4.17.-</RegistryNumber>
<NameOfSubstance UI="C413524">angiotensin converting enzyme 2</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012084" MajorTopicYN="N">Renin-Angiotensin System</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">ACE2</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Mechanisms</Keyword>
</KeywordList>
<CoiStatement>Declaration of competing interest The authors have no conflict of interest.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>04</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>04</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>04</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>4</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>6</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>4</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32305506</ArticleId>
<ArticleId IdType="pii">S0300-9084(20)30078-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.biochi.2020.04.008</ArticleId>
<ArticleId IdType="pmc">PMC7161528</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>France</li>
<li>Italie</li>
</country>
<region>
<li>Île-de-France</li>
</region>
<settlement>
<li>Paris</li>
</settlement>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Alifano, Marco" sort="Alifano, Marco" uniqKey="Alifano M" first="Marco" last="Alifano">Marco Alifano</name>
</noRegion>
<name sortKey="Forgez, Patricia" sort="Forgez, Patricia" uniqKey="Forgez P" first="Patricia" last="Forgez">Patricia Forgez</name>
<name sortKey="Iannelli, Antonio" sort="Iannelli, Antonio" uniqKey="Iannelli A" first="Antonio" last="Iannelli">Antonio Iannelli</name>
</country>
<country name="Italie">
<noRegion>
<name sortKey="Alifano, Pietro" sort="Alifano, Pietro" uniqKey="Alifano P" first="Pietro" last="Alifano">Pietro Alifano</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000769 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000769 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32305506
   |texte=   Renin-angiotensin system at the heart of COVID-19 pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32305506" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021